XFRA:IV1 ERBA Diagnostics Inc Quarterly Report 10-Q/A Filing - 6/30/2012

Effective Date 6/30/2012

XFRA:IV1 Fair Value Estimate
Premium
XFRA:IV1 Consider Buying
Premium
XFRA:IV1 Consider Selling
Premium
XFRA:IV1 Fair Value Uncertainty
Premium
XFRA:IV1 Economic Moat
Premium
XFRA:IV1 Stewardship
Premium
 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2012

 

Commission File Number 1-14798

 

ERBA DIAGNOSTICS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   11-3500746
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

2140 North Miami Avenue, Miami, Florida 33127

(Address of principal executive offices) (Zip Code)

 

(305) 324-2300

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
   
Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

 

34,991,554 shares of Common Stock, $ .01 par value, outstanding as of August 28, 2012.

 

 
 

 

Explanatory Note

 

The sole purpose of this Amendment No. 1 to ERBA Diagnostics, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 13, 2012 (the “Form 10-Q”), is to furnish as exhibits to the Form 10-Q, pursuant to Rule 405 of Regulation S-T promulgated by the Securities and Exchange Commission, the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).

 

No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the Form 10-Q.

 

 
 

 

PART II - OTHER INFORMATION

 

Item 6 – Exhibits

 

Exhibit    
Number   Description
     
3.1   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Appendix A of our Schedule 14A filed on May 24, 2012)
4.1   Specimen of Common Stock Certificate*
10.1   Use of Name License Agreement, effective as of June 15, 2012, by and between ERBA Diagnostics, Inc. (f/k/a IVAX Diagnostics, Inc.) and ERBA Diagnostics Mannheim GmbH (incorporated by reference to our Form 8-K filed on June 20, 2012)
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
32.2   Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101.INS   XBRL Instance Document***
101.SCH   XBRL Taxonomy Extension Schema Document***
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document***
101.LAB   XBRL Taxonomy Extension Labels Linkbase Document***
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document***
101.DEF   XBRL Taxonomy Extension  Definition Linkbase Document***

 

 

*Previously filed with our Form 10-Q filed with the Securities and Exchange Commission on August 13, 2012.
**Previously furnished with our Form 10-Q filed with the Securities and Exchange Commission on August 13, 2012.
***Pursuant to Rule 406T of Regulation S-T promulgated by the Securities and Exchange Commission, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under these sections.

 

 
 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ERBA Diagnostics, Inc.
   
Date:  August 29, 2012 By: /s/Arlene Rodriguez
    Arlene Rodriguez,
    Controller

 

 
 

 

EXHIBIT INDEX

 

Exhibit    
Number   Description
     
101.INS   XBRL Instance Document*
101.SCH   XBRL Taxonomy Extension Schema Document*
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document*
101.LAB   XBRL Taxonomy Extension Labels Linkbase Document*
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document*
101.DEF   XBRL Taxonomy Extension  Definition Linkbase Document*

 

 

*Pursuant to Rule 406T of Regulation S-T promulgated by the Securities and Exchange Commission, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under these sections.

 

 

 

XFRA:IV1 ERBA Diagnostics Inc Quarterly Report 10-Q/A Filling

ERBA Diagnostics Inc XFRA:IV1 Stock - Get Quarterly Report SEC Filing of ERBA Diagnostics Inc XFRA:IV1 stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XFRA:IV1 ERBA Diagnostics Inc Quarterly Report 10-Q/A Filing - 6/30/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XFRA:IV1 ERBA Diagnostics Inc Quarterly Report 10-Q/A Filing - 3/31/2012  |  Next: XFRA:JHA James Hardie Industries PLC DR Annual Report 20-F Filing - 3/31/2012